Showing 9911-9920 of 19124 results for "".
- Genetic Influences and Treatment Response in Myopiahttps://reachmd.com/news/genetic-influences-and-treatment-response-in-myopia/2475625/Orthokeratology lenses have become an increasingly popular strategy to slow myopic progression, yet substantial interindividual variability in their effectiveness remains. A recent study
- AI-Driven Imaging Innovations Elevate Radiological Precisionhttps://reachmd.com/news/ai-driven-imaging-innovations-elevate-radiological-precision/2475611/Radiologists aiming for high-fidelity tissue characterization face persistent workflow complexity and resource limitations in advanced imaging modalities. Emerging AI-powered, open-source software is now streamlining fluorescence lifetime ima
- The Menace of Acinetobacter baumannii: Innovative Strategies Against a Stealthy Superbughttps://reachmd.com/news/the-menace-of-acinetobacter-baumannii-innovative-strategies-against-a-stealthy-superbug/2475608/In the age of rising antimicrobial resistance, Acinetobacter baumannii emerges as a formidable pathogen with complex resistance mechanisms. Infectious disease specialists now confront a silent escalation within hospital wards: Acin
- Gut Microbiome: Impact of Bifidobacterium Deficit on Childhood Allergy and Eczema Riskshttps://reachmd.com/news/gut-microbiome-impact-of-bifidobacterium-deficit-on-childhood-allergy-and-eczema-risks/2475622/A major new study examining the gut microbiome of American infants has revealed a striking absence of critical Bifidobacterium species—microbes long recognized for their foundational role in early imm
- Upcoming Skin Cancer Champions Webinar Addresses Impact of AIhttps://reachmd.com/news/Upcoming-Skin-Cancer-Champions-Webinar-Addresses-Impact-AI/2475627/Veronica Rotemberg, MD, PhD, will host a free webinar on the future of non-melanoma skin cancer care August 5 at 1:00 PM ET, Skin Cancer Champions announced. Dr. Rotemberg, Director of Dermatology Imaging Informatics for Memorial Sloan Kettering Cancer Center, will present “The Future of S
- Advancing Selective Mutism Diagnosis and Intervention in Early Childhoodhttps://reachmd.com/news/advancing-selective-mutism-diagnosis-and-intervention-in-early-childhood/2475592/Selective mutism typically has an onset between ages three and six, with diagnosis often occurring after school entry, from ages five to eight, as its presentation overlaps with typical shyness and other anxiety disorders. Selective mu
- Increasing Skin-to-Skin Contact Through Targeted Training: Transforming Neonatal Carehttps://reachmd.com/news/increasing-skin-to-skin-contact-through-targeted-training-transforming-neonatal-care/2475587/Clinicians learning that targeted skin-to-skin contact training can significantly increase participation within 48 hours post-birth indicates a significant improvement in neonatal care practices. Despite evidence from systematic review
- Harnessing AI and Advanced Imaging for Early Cancer Detectionhttps://reachmd.com/news/harnessing-ai-and-advanced-imaging-for-early-cancer-detection/2475578/Recent advancements in cancer detection are being propelled by the integration of artificial intelligence and advanced imaging technologies into diagnostic workflows, providing significant opportunities for early and accurate identification of malignancies. The pursuit of higher diagnostic
- Addressing Gender Disparities in Physician-Patient Interactions for Hidradenitis Suppurativahttps://reachmd.com/news/addressing-gender-disparities-in-physician-patient-interactions-for-hidradenitis-suppurativa/2475585/Addressing gender disparities in physician-patient interactions can enhance treatment outcomes for hidradenitis suppurativa (HS) patients. Dermatologists managing Hidradenitis Suppurativa may sometimes overlook how gender differences s
- Understanding RNA Networks in Colorectal Cancer: Implications for Precision Immunotherapyhttps://reachmd.com/news/understanding-rna-networks-in-colorectal-cancer-implications-for-precision-immunotherapy/2475591/The growing understanding of RNA networks, especially long non-coding RNAs (lncRNAs), in the progression of colorectal cancer and their role in immune interactions, has revealed possible molecular weaknesses that could guide the development o